Introduction {#s1}
============

Mitochondria are double membrane-bound organelles whose shape is instrumental to their function in diverse cellular processes such as metabolism and apoptosis ([@bib27]). The inner mitochondrial membrane has the highest density of protein in the cell and is differentiated into three distinct interconnected domains: the boundary region, which are flattened membranes that lie in close apposition to the outer membrane; cristae membranes, which are lamellar invaginations with highly curved edges; and cristae junctions, which are relatively narrow tubules that connect cristae to the boundary membrane and may act as a physical partitioning mechanism that prevents and/or regulates the intermixing of proteins between cristae and the boundary domains ([@bib30]). Compositionally, the boundary membrane is enriched for import and assembly machinery for the mitochondrial proteome ([@bib51]; [@bib57]). In contrast, cristae membranes house assembled electron transport chain protein complexes and ATP synthase, which function together to synthesize ATP via oxidative phosphorylation. Specific combinations of electron transport chain complexes further assemble into large mega-Dalton supercomplexes in cristae in a manner dependent on the mitochondrial lipid cardiolipin and act to facilitate electron transport, and likely as diffusion traps to promote their sorting into cristae ([@bib9]; [@bib60]; [@bib39]; [@bib2]; [@bib28]; [@bib55]). ATP synthase also assembles in a regulated manner into dimers and dimer oligomers, whose unique structure generates and/or stabilizes the high curvature at the edges of lamellar cristae ([@bib1]; [@bib37]; [@bib49]).

The proper differentiation of the mitochondrial inner membrane into separate domains is critical for mitochondrial function. Indeed, a hallmark feature of mitochondrial diseases is aberrant mitochondrial ultrastructure and shape ([@bib61]). Inner membrane structure is also a critical feature of apoptosis, where cristae junctions are remodeled to facilitate the release of the cell death mediator, cytochrome *c* ([@bib46]). Internal mitochondrial architecture may also interface with the external mitochondrial environment, including contacts with the endoplasmic reticulum (ER) as nucleoids associate with both mitochondrial cristae and mitochondrial division sites, which are marked by sites of ER contact ([@bib6]; [@bib24]; [@bib35]). Thus, proper mitochondrial ultrastructure is critical for a multitude of mitochondrial and cellular functions.

The mechanisms by which inner membrane domains are established and maintained are poorly understood. In addition to respiratory supercomplexes, ATP synthase oligomers and mitochondrial lipid composition, the inner membrane fusion dynamin, Mgm1/OPA1, and scaffolding proteins such as prohibitins have been proposed to play roles in inner membrane structure ([@bib12]; [@bib31]; [@bib33]). These factors are interdependent---for example, cardiolipin is required for both respiratory supercomplex assembly and Mgm1/OPA1 self-assembly and function and the prohibitins are required to maintain normal mitochondrial lipid homeostasis ([@bib11]; [@bib36]). This interdependency suggests that inner membrane differentiation is a highly cooperative process, however, exactly how these determinants work together to correctly shape and organize the mitochondrial membrane to ultimately lead to proper respiratory function is also not understood.

The recently identified MICOS complex (previously named MitOS or MINOS) has been proposed to act as a master regulator/integrator of mitochondrial inner membrane shape and organization ([@bib17]; [@bib20]; [@bib52]; [@bib3]; [@bib38]). Consistently, MICOS interacts both physically and functionally with cardiolipin, import machinery, and respiratory complexes ([@bib40]; [@bib20]; [@bib5]; [@bib25]; [@bib59]; [@bib53]; [@bib18]). The MICOS complex is also embedded in the inner membrane with domains facing the intermembrane space that mediate the formation of heterologous structures localized to the inner boundary membrane ([@bib20]). It is comprised of six core subunits in yeast: Mic60, Mic10, Mic19, Mic27, Mic26, and Mic12, that, with the exception of Mic12, have mammalian homologs ([@bib58]; [@bib34]; [@bib10]; [@bib19]; [@bib3]; [@bib4]; [@bib53]). Single MICOS subunit deletion causes a characteristic mitochondrial inner membrane morphological defect in cells, consisting of extended, stacked, lamellar inner membranes and a reduction of the number of cristae junctions, with a consequent lamellar mitochondrial shape defect. The common cellular phenotypes of single MICOS subunit deletions indicate that they perform a shared function. However, expression analysis indicates that Mic60 and Mic10 function uniquely as 'core components' that direct a hierarchal MICOS assembly as *MIC60* deletion causes Mic19 instability and *MIC10* deletion causes Mic27 instability ([@bib17]; [@bib20]; [@bib52]). In addition, specific pairwise combinations of MICOS subunit deletions can produce either positive or negative genetic interactions ([@bib20]), indicating that although MICOS subunits act cooperatively, they also perform non-redundant roles within mitochondria. For example, Mic60 plays a role in import independently of the MICOS complex ([@bib52]).

Here we examine the role of MICOS in the lateral organization of the mitochondrial inner membrane by examining how MICOS is assembled and how MICOS cooperates with the surrounding mitochondrial environment. Using yeast cells deficient for all six components of MICOS, we identify two major MICOS organizing centers, Mic60 and Mic27/Mic10/Mic12. Our data indicate that Mic27/Mic10/Mic12 assembles at cristae junctions in a respiratory complex- and cardiolipin-dependent manner. In contrast, Mic60 assembles and organizes independently of other MICOS subunits, cardiolipin, and the respiratory machinery, suggesting that Mic60 assemblies may intrinsically mark nascent cristae junctions. MICOS subcomplexes are bridged together by Mic19, which our data indicates controls the copy number and position of cristae junctions within mitochondria. Together, our findings demonstrate how the MICOS complex works with respiratory complexes and the mitochondria lipid environment to establish inner membrane architecture, organization and function.

Results {#s2}
=======

The MICOS complex is required for oxidative phosphorylation and normal mitochondrial ultrastructure and morphology {#s2-1}
------------------------------------------------------------------------------------------------------------------

To address the functional roles and organization of MICOS, we generated a yeast strain lacking all core MICOS components using a Cre-*lox* recombination system, which allowed for sequential MICOS subunit gene deletion and selection marker rescue ([@bib16]). Using this approach, we constructed ∆MICOS---a strain containing 'clean,' unmarked deletions of all six MICOS genes. In contrast to single MICOS subunit deletions, ∆MICOS cells displayed a severe respiratory growth defect, as assessed by growth on the non-fermentable carbon source, glycerol ([Figure 1A](#fig1){ref-type="fig"}, right panel). Importantly, reintroduction of four of six MICOS genes at their native loci complemented the growth defect, validating the ∆MICOS strain ([Figure 1A](#fig1){ref-type="fig"}). The mitochondrial morphology defect of the ∆MICOS strain, as assessed by fluorescence microscopy using the matrix-targeted fluorescent protein, mito-DsRed, was also more penetrant as compared to mitochondria in individual MICOS deletion cells ([Figure 1B](#fig1){ref-type="fig"}). Although the predominant lamellar shape phenotype present in single MICOS deletion mutants was observed (56% of ∆*mic60* cells vs 21% of ∆MICOS cells), a majority of ∆MICOS cells also had bulbous mitochondrial structures with a beads on a string appearance, and hollow, large spherical structures that were sometimes continuous with the bulbous structures (11% of ∆*mic60* cells vs 59% of ∆MICOS cells) ([Figure 1C](#fig1){ref-type="fig"}). These spherical structures are consistent with what have previously observed in a relatively small fraction of ∆*mic60* cells ([@bib21]). EM analysis of ∆MICOS cells revealed mitochondrial features analogous to those observed by fluorescence microscopy, including extended lamellar cristae, septated inner membranes, mitochondria with larger diameter structures, and hollow mitochondria, respectively ([Figure 1D](#fig1){ref-type="fig"}).10.7554/eLife.07739.003Figure 1.The MICOS complex is required for oxidative phosphorylation and normal mitochondrial ultrastructure and morphology.(**A**) Serial dilutions of the indicated yeast cells were plated on media containing glucose (left) and the non-fermentable carbon source, glyercol (right). (**B**) Mitochondrial morphology in the indicated strains was determined by imaging cells expressing the matrix marker mito-dsRed. Z-projections of confocal fluorescence images are shown, except for the right panel of ∆MICOS, which is a single plane. (**C**) Quantification of mitochondrial morphologies from cells imaged as in (**B**) were categorized. Approximately 100 cells from three independent experiments were quantified and data are represented as mean ± SEM. (**D**) Representative electron microscopy images are shown of chemically fixed yeast cells from the indicated strains. (**E**) Confocal fluorescence microscopy z-projections of cells from the indicated strains expressing mito-DsRed and the functional nucleoid marker Rim1-GFP are shown. The arrow marks aggregation of Rim1-GFP in a ∆MICOS cell. Scale bars: (**B**) 2 μm; (**D**) 500 nm; (**E**) 3 μm. See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.003](10.7554/eLife.07739.003)10.7554/eLife.07739.004Figure 1---figure supplement 1.Rim1 is a functional marker of nucleoids.(**A**) Serial dilutions of the wild type yeast and those expressing Rim1-GFP integrated at the *trp1* locus plated on media containing glucose (left) and the non-fermentable carbon source, glyercol (right). (**B**) Z-projections of confocal fluorescence microscopy images of wild type rho^+^ (top) and rho^0^ (bottom) cells expressing Rim1-GFP and the mitochondrial matrix marker, mito-DsRed. Scale bar: 3 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.004](10.7554/eLife.07739.004)

We examined the distribution of mitochondrial genomes by imaging cells expressing a tagged mitochondrial DNA-binding protein, Rim1-GFP, a functional marker of nucleoids ([@bib50]) ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). In wild type and ∆*mic60* cells, genomes were relatively uniformly distributed throughout mitochondria, however in ∆*mic60* cells, nucleoids localized to the edge of lamellar mitochondrial regions, suggesting they may be excluded from regions of stacked, lamellar inner membranes ([Figure 1E](#fig1){ref-type="fig"}). In ∆MICOS cells, while Rim1-marked nucleoids were maintained, a fraction of nucleoids appeared aggregated as compared to in wild type cells (marked by an arrow in [Figure 1E](#fig1){ref-type="fig"}). Aggregated nucleoids were mostly observed in spherical mitochondria in ∆MICOS cells, a phenotype previously observed in a relatively smaller fraction of ∆*mic60* and ∆*mic10* cells ([@bib21]). Our characterization of ∆MICOS cells indicates that, although MICOS subunits have non-redundant functions, they act together to buffer the loss of function caused by deletion of single components. However, these observations point to the critical role of the intact MICOS complex in the maintenance of mitochondrial function, morphology, and distribution of mitochondrial genomes in cells.

Mic60 assembles independently of other MICOS members and Mic19 regulates its distribution within mitochondria {#s2-2}
-------------------------------------------------------------------------------------------------------------

Members of the MICOS complex are localized in a non-uniform focal-like pattern along the inner membrane in both yeast and mammalian cells ([@bib20]; [@bib22]) ([Figure 2A](#fig2){ref-type="fig"}). These substructures have been postulated to reflect a scaffold-like function of the complex at cristae junctions ([@bib20]). To gain insight into the molecular basis and functional significance of MICOS organization, we utilized the ∆MICOS strain as a tool to examine the formation of mitochondrial substrctures using functional fluorescent protein tagged versions of MICOS components re-integrated at their respective loci. With the exception of Mic10, all C-terminal fluorescent protein-tagged MICOS subunits were functional based on their ability to maintain wild type-like tubular mitochondria in a wild type cell background ([Figure 2A](#fig2){ref-type="fig"}). In contrast to wild type cells, in ∆MICOS cells the distribution observed for MICOS components Mic27, Mic19, Mic12 and Mic26 was uniform, similar to the matrix marker ([Figure 2B](#fig2){ref-type="fig"}). Mic60, however, uniquely localized to discrete foci in a majority of ∆MICOS cells ([Figure 2B,F](#fig2){ref-type="fig"}), indicating that Mic60 localizes to substructures independent of its interaction with the MICOS complex, suggesting that Mic60 may have an intrinsic ability to self-assemble.10.7554/eLife.07739.005Figure 2.Mic60 self-assembles independently and its inner membrane distribution is regulated by Mic19.(**A**) Z-projections of representative deconvolved fluorescence microscopy images are shown from wild type yeast cells expressing the indicated integrated GFP-tagged MICOS protein and mito-DsRed. The yellow box indicates the region of the cell shown in the inset below. The inset displays a single plane. (**B**) Representative images are shown as in (**A**) for ∆MICOS cells expressing the indicated GFP-tagged MICOS proteins re-integrated at their endogenous loci. The arrows mark sites of Mic60 localization to foci. (**C**) The distribution of Mic60-EGFP in ∆MICOS cells was determined as in (**B**) with the indicated untagged MICOS proteins re-integrated at their endogenous loci. (**D**) Representative Western blot analysis with the indicated antibodies are shown of whole cell lysates (left panel) and immunoprecipitation eluates (IPs; right panel) from ∆MICOS cells expressing either Mic60-FLAG or Mic60-EGFP at the *MIC60* locus, and where indicated, expressing Mic60-EGFP from the *ura3* locus using the *MIC60* promoter (pMic60-EGFP). G6PDH antibody was used as a loading control. IPs were performed with the indicated antibodies. The asterisk marks a band consistent with the size of IgG heavy chain. (**E**) Western blot analysis with the indicated antibodies of total (T), supernatant (S), and insoluble (P) fractions of detergent-solubilized mitochondria isolated from wild type (left) or ∆MICOS (right) cells expressing Mic60-EGFP and centrifuged at 50,000×*g* for 1 hr, a condition that pellets particles of 60S and greater. (**F**) A graph showing the percentage of cells with detectable Mic60 foci from ∆MICOS cells without and with Mic19 expression as shown in (**B**) and (**C**). Approximately 75 cells from three independent experiments were quantified and data are represented as mean ± SEM. (**G**) Table describing the number of total spectra and protein coverage for the indicated proteins (top) from purifications and mass spectrometry analysis using FLAG antibody from ∆MICOS cell lysate expressing the indicated combinations of Mic60 and Mic19 (left) expressed at their endogenous loci. Data shown are the mean of two independent experiments. Scale bars: (**A**--**B**) 3 μm; (**C**) 2 μm. See also [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.005](10.7554/eLife.07739.005)10.7554/eLife.07739.006Figure 2---figure supplement 1.Overexpression of Mic60 does not alter its focal localization in ∆MICOS cells.Confocal fluorescence microscopy z-projections of ∆MICOS cells expressing mito-DsRed and Mic60-EGFP expressed at its endogenous locus (left) or Mic60-FLAG from the *MIC60* locus and pMic60-EGFP expressed from the *ura3* locus (right). Arrows mark sites of focal Mic60. Scale bar: 3 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.006](10.7554/eLife.07739.006)

To test this possibility, we performed proteomic analysis of ∆MICOS cells expressing both FLAG-tagged Mic60 at its endogenous locus and EGFP-tagged Mic60 integrated at a second locus driven by its native promoter (pMic60-EGFP). The mild overexpression of Mic60 as a consequence of two genomic copies did not interfere with the ability of pMic60-EGFP to localize to foci ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Purification of Mic60 from cross-linked extract from these cells using either α-FLAG or α-GFP antibodies specifically co-purified both tagged Mic60 versions by Western blot analysis ([Figure 2D](#fig2){ref-type="fig"}). To rule out the possibility that Mic60 foci represent insoluble aggregates, we solubilized mitochondria isolated from wild type and ∆MICOS cells expressing Mic60-EGFP using the non-ionic detergent, Triton X-100, under relatively low ionic conditions and subjected extracts to ultracentrifugation. As in wild type cells, Mic60-EGFP expressed in ∆MICOS cells remained soluble, indicating that Mic60 foci represent assembled structures ([Figure 2E](#fig2){ref-type="fig"}). These data indicate that Mic60 self-interacts in the absence of other MICOS members and suggest that Mic60 foci in ∆MICOS may represent self-assemblies.

To test the relationship of Mic60-labeled structures to MICOS, we examined the effect of expression of other MICOS complex subunits re-integrated at their respective loci on Mic60 localization. Expression of Mic10, Mic12, Mic26, or Mic27 had no apparent effect on Mic60 foci formation or frequency ([Figure 2C](#fig2){ref-type="fig"}). In contrast, expression of Mic19 caused Mic60 to become more distributed within mitochondria as compared to the matrix marker, with only 20% of ∆MICOS + Mic19 cells possessing Mic60-EGFP foci as compared to 80% in cells expressing Mic60-EGFP alone ([Figure 2C,F](#fig2){ref-type="fig"}). The unique dependence on Mic19 for Mic60 distribution in ∆MICOS cells is consistent with the dependence of Mic19\'s stability on Mic60 in wild type cells ([@bib17]; [@bib20]; [@bib52]). To gain insight into the molecular basis of the effect of Mic19 on Mic60 distribution, we performed purifications using α-FLAG antibody and mass spectrometry analysis from cross-linked cell extracts of ∆MICOS strains expressing Mic60-FLAG and untagged Mic19, or Mic19-FLAG and untagged Mic60, expressed from their endogenous loci. In each purification, we identified both Mic60 and Mic19 ([Figure 2G](#fig2){ref-type="fig"}), suggesting that Mic19 interacts directly with Mic60 independently of other MICOS subunits and that Mic19, in part, functions within MICOS to regulate the distribution of Mic60 along the inner membrane.

Mic10, Mic12, and Mic27 form a second independent MICOS organizing center {#s2-3}
-------------------------------------------------------------------------

Given that Mic60 is able to label discrete structures independently of other MICOS complex members, we tested whether Mic60 was required for the focal distribution of other MICOS subunits. Consistent with the requirement of Mic60 for wild type Mic19 expression, Mic19 in ∆*mic60* cells, as detected using fluorescence microscopy, was relatively faint and uniformly labeled the mitochondrial membrane as compared to the matrix marker mito-DsRed ([Figure 3A](#fig3){ref-type="fig"} vs [Figure 2A](#fig2){ref-type="fig"}). In the absence of Mic60, Mic26 also localized uniformly, similar to the matrix marker ([Figure 3A](#fig3){ref-type="fig"}). In contrast, Mic12 and Mic27 both localized in a non-uniform pattern within mitochondria; this phenotype was most prominent for Mic27, which localized to distinct and relatively bright punctate structures in a majority of cells ([Figure 3A](#fig3){ref-type="fig"}, marked by arrows, and [Figure 3F](#fig3){ref-type="fig"}). This suggests that Mic27, and to a lesser extent Mic12, localize to mitochondrial sub-structures in a Mic60-independent manner.10.7554/eLife.07739.007Figure 3.Mic10, Mic12, and Mic27 form an independent MICOS subcomplex.(**A**) Confocal fluorescence microscopy z-projections are shown from ∆*mic60* cells expressing the indicated GFP-tagged MICOS proteins expressed at their endogenous loci and the mitochondrial matrix marker mito-DsRed. The arrows shown mark the focal localization of Mic27 and Mic12. (**B**) Localization of Mic27-mCherry compared to the matrix marker mito-GFP was determined in the indicated MICOS deletion cells by confocal fluorescence microscopy as in (**A**). The arrows mark examples of Mic27 foci. (**C**) Images are shown as in (**A**) for ∆MICOS cells expressing Mic27-EGFP and the indicated untagged MICOS proteins expressed at their endogenous loci. The arrows mark Mic27 foci. (**D**) A graph displaying quantification of the percent of cells as in (**C**) with the indicated number of Mic27-EGFP foci per cell. Approximately 75 cells from three independent experiments were counted and data shown are represented as the mean ± SEM. (**E**) Images are shown as in (**B**) for the indicated yeast cells. (**F**) Quantification as in (**D**) for the cells shown as in (**E**). (**G**) A graph depicting the number of total spectral counts identified by mass spectrometry of the indicated MICOS proteins from lysates of ∆*mic60* cells relative to wild type cells from purifications of Mic27-EGFP with GFP antibody. Data shown are the mean and range of two independent experiments. Scale bars: (**A**, **B**) 2 μm; (**C**, **D**) 3 μm. See also [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.007](10.7554/eLife.07739.007)10.7554/eLife.07739.008Figure 3---source data 1.Table listing spectral count and percent coverage data from mass spectrometry analysis of indicated MICOS protein purifications from the indicated strains.Data from table are presented graphically in [Figures 3G, 4C](#fig3 fig4){ref-type="fig"}. In some cases, multiple experiments were performed simultaneously with a single control experiment.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.008](10.7554/eLife.07739.008)

We further characterized the nature of the Mic27 sub-structures by examining the localization of Mic27 in the absence of each of the MICOS subunits in cells. In the case of ∆*mic26 and* ∆*mic12* cells, Mic27 had similar non-uniform mitochondrial labeling as observed in wild type cells ([Figure 3B](#fig3){ref-type="fig"}). In ∆*mic10* cells, Mic27 uniformly labeled mitochondria and the fluorescence signal was relatively weaker than in wild type cells, consistent with the observation that Mic10 is required for Mic27 stability. However, in addition to ∆*mic60* cells, Mic27 localized to bright foci in ∆*mic19* cells, in which there is stable Mic60 expression ([@bib17]) ([Figure 3B](#fig3){ref-type="fig"}, marked by arrows). This observation is consistent with our data suggesting that Mic60 and Mic19 form a complex and function together in a cooperative manner within MICOS ([Figure 2](#fig2){ref-type="fig"}). More significantly, because Mic60 is required for Mic19 stability, it seems likely that the altered localization of Mic27 to more pronounced mitochondrial foci/substructures is a direct consequence of a loss of Mic19 and suggests that these structures represent a second MICOS organizing center.

The formation of the Mic27 substructures requires other MICOS subunits as these structures were not observed when Mic27 is expressed alone in ∆MICOS cells ([Figure 2B](#fig2){ref-type="fig"}). To determine the minimal MICOS proteins required for Mic27 substructure formation, we re-integrated unmarked MICOS subunits into ∆MICOS cells expressing Mic27-EGFP at its endogenous locus. Consistent with the requirement of Mic10 for Mic27 stability in wild type cells, the addition of Mic10 was sufficient for Mic27 substructures to form, however, their frequency was significantly less than that observed in either ∆*mic19* or ∆*mic60* cells ([Figure 3C,D](#fig3){ref-type="fig"}). Expression of Mic12 in addition to Mic10, however, supported the formation of Mic27-EGFP substructures at a frequency almost equal to that observed in ∆*mic19* or ∆*mic60* cells (compare [Figure 3D,3F](#fig3){ref-type="fig"}). Thus, MICOS subunits Mic10 and Mic12 are sufficient for Mic27 substructures to form, suggesting that these three proteins exist as an independent MICOS subcomplex.

To further test this idea, we asked whether Mic10 or Mic12 were required for Mic27 substructure formation in ∆*mic60* cells. Mic27 substructures were largely undetectable in ∆*mic60* ∆*mic10* cells, consistent with the requirement of Mic10 for Mic27 stability ([Figure 3E--F](#fig3){ref-type="fig"}). We also observed that Mic12 plays a role in Mic27 substructure formation, as the percentage of cells containing Mic27 foci was significantly lower in the absence of Mic12 ([Figure 3F](#fig3){ref-type="fig"}). Thus, together our data indicate that Mic10 and Mic12 are both necessary and sufficient for Mic27 substructure assembly and suggest that these proteins form an independent MICOS subcomplex.

To directly test this possibility, we purified EGFP-tagged Mic27 from cross-linked lysates of wild type and ∆*mic60* cells using α-GFP antibody and identified MICOS subunits by mass spectrometry-based proteomic analysis. Consistent with previous results, proteomic analysis of purifications of Mic27-EGFP in wild type cells robustly identified the entire MICOS complex as assessed by both the number of peptide spectral counts and percent coverage of MICOS subunits ([@bib20]) ([Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}). To examine Mic27 substructure composition, we directly compared spectral counts of MICOS subunits by normalizing the total number of Mic27 peptide spectral counts purified from ∆*mic60* extracts relative to wild type extracts. As expected, purification of Mic27-EGFP from ∆*mic60* extracts did not identify Mic60 or Mic19; however, significant relative peptide spectral counts were observed for Mic10, and to a lesser extent, for Mic12 ([Figure 3G](#fig3){ref-type="fig"} and [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}). In total, the data indicate that there are two distinct MICOS organizing centers: Mic60, which may have an intrinsic self-organizational capacity and interacts with Mic19, and a complex containing Mic27, which is dependent on Mic12 and Mic10 for assembly.

Mic27 assemblies mark cristae junctions {#s2-4}
---------------------------------------

Because of the severe respiratory defect of the ∆MICOS strain and the interrelationship between respiratory complexes and MICOS for generating mitochondrial inner membrane shape ([@bib20]), we tested whether respiratory complexes are required for Mic60 and Mic27 assembly formation. To block the assembly of mitochondrial respiratory complexes, we generated strains that lack mtDNA (rho^0^) and examined the distribution of the two MICOS subcomplexes as marked by either Mic60 foci (in ∆MICOS + Mic60-EGFP cells) or Mic27 foci (in ∆*mic60* + Mic27-mCherry cells). We observed that Mic60 foci in ∆MICOS persisted in a majority of rho^0^ cells (foci in 80% of rho^+^ cells vs 64% of rho^0^ cells; [Figure 4A--B](#fig4){ref-type="fig"}). In contrast, although steady state expression level of Mic27 in ∆*mic60* rho^0^ cells was similar to in rho^+^ cells, Mic27 assemblies were absent in rho^0^ cells (foci in 86% of rho^+^ cells vs 3% of rho^0^ cells; [Figure 4A--B](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). In ∆*mic60* rho^0^ cells, the absence of Mic27 foci corresponded to a loss of its interaction with Mic10 and Mic12 as assessed by mass spectrometry-based proteomic analysis of Mic27 purifications ([Figure 4C](#fig4){ref-type="fig"} and [Figure 4---source data 1A](#SD2-data){ref-type="supplementary-material"}). The loss of Mic27 subcomplex interactions is due specifically to the combination of mtDNA loss and the absence of Mic60, as Mic27 co-purified with the entire MICOS complex in wild type rho^0^ cells as assessed by mass spectrometry analysis of Mic27 purifications ([Figure 4---source data 1B](#SD2-data){ref-type="supplementary-material"}). These data reveal that the Mic27/Mic10/Mic12 subcomplex is selectively dependent on the presence of mtDNA, suggesting a critical role of respiratory complexes in the assembly and/or stabilization of this MICOS subcomplex.10.7554/eLife.07739.009Figure 4.Mic27 assemblies mark cristae junctions.(**A**) Z-projections of confocal fluorescence microscopy images of (left) ∆MICOS cells expressing Mic60-EGFP at the *MIC60* locus and mito-DsRed or (right) ∆*mic60* cells expressing Mic27-mCherry at its endogenous locus and mito-GFP. Cells are rho^+^ or rho^0^ where indicated. (**B**) Quantification of cells from (**A**) is shown indicating the number of cells with detectable Mic60 or Mic27 foci, as indicated. Approximately 75 cells from three independent experiments were counted and the data shown are represented as the mean ± SEM. Data from rho^+^ cells for Mic60 and Mic27 are redisplayed from [Figures 2F](#fig2){ref-type="fig"}, [3F](#fig3){ref-type="fig"}, respectively. (**C**) A graph depicting the number of total spectral counts identified by mass spectrometry of the indicated MICOS proteins from lysates of ∆*mic60* rho^+^ and rho^0^ cells relative to wild type cells from purifications of Mic27-EGFP with GFP antibody. Data shown are the mean and range of two independent experiments and data for rho^+^ cells are redisplayed from [Figure 3G](#fig3){ref-type="fig"}. (**D**) Single plane confocal fluorescence microscopy images in 0.4 µm steps through a ∆*mic60* cell expressing Mic27-EGFP and the Complex III marker Qcr2-mCherry at their endogenous loci and the mitochondrial matrix marker mito-TagBFP. Arrows indicate Mic27 foci identified and analyzed in (**E**). (**E**) Top row: individual channels and a merged image of a maximum z-projection image of the cell shown in (**D**). Bottom row: from left to right, a tracing of mitochondria, Qcr2 signal above the threshold detected by the 'Moments' algorithm of ImageJ, Mic27 foci identified in the z-projection, and a merged image indicating regions of the mitochondrial perimeter positive for Qcr2 signal and their position relative to Mic27 foci. (**F**) Quantification of the total percentage of mitochondrial perimeter considered positive for Qcr2 signal and the number of Mic27 foci localized to mitochondrial subregions positive for Qcr2 from cells in (**E**) and [Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}. Scale bars: (**A**) 3 μm; (**D**--**E**) 1 μm. See also [Figure 4---figure supplements 1--5](#fig4s1 fig4s2 fig4s3 fig4s4 fig4s5){ref-type="fig"} and [Figure 4---source data 1](#SD2-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.009](10.7554/eLife.07739.009)10.7554/eLife.07739.010Figure 4---source data 1.Tables listing spectral count and percent coverage data from mass spectrometry analysis of indicated MICOS protein purifications from the indicated strains.Data from table (**A**) are presented graphically in [Figures 3G, 4C](#fig3 fig4){ref-type="fig"}, and this table is redisplayed from [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}. Data from table (**B**) are not presented graphically.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.010](10.7554/eLife.07739.010)10.7554/eLife.07739.011Figure 4---figure supplement 1.Steady-state Mic27 expression levels are maintained in ∆*mic60* rho^0^ cells compared to rho^+^ cells.Western blot analysis of whole cell lysates prepared from the indicated strains expressing Mic27-mCherry from its endogenous locus and detected with antibody against mCherry. G6PDH was used as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.011](10.7554/eLife.07739.011)10.7554/eLife.07739.012Figure 4---figure supplement 2.Individual respiratory complexes are not essential for Mic27 foci formation.(**A**) Z-projections of confocal fluorescence microscopy images of the indicated yeast cells expressing mito-GFP and Mic27-mCherry expressed from its endogenous locus. (**B**) Quantification of the percent of cells with detectable Mic27 foci in the indicated cells as in (**A**). Data shown are represented as the mean ± SEM from three independent experiments with approximately 75 cells counted per experiment. Data from ∆*mic60* cells are redisplayed from [Figure 3F](#fig3){ref-type="fig"}. Scale bars: 3 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.012](10.7554/eLife.07739.012)10.7554/eLife.07739.013Figure 4---figure supplement 3.Qcr2 and Atp2 are functional markers of Complex III and V, respectively, and localize to sub-mitochondrial regions in ∆*mic60* cells.(**A**) Serial dilutions of the yeast cells expressing the indicated markers expressed from their endogenous loci plated on media containing glucose (left) and the non-fermentable carbon source, glyercol (right). (**B**) Confocal fluorescence microscopy z-projections of wild type yeast cells expressing mito-GFP as well as Qcr2-mCherry (left) or Atp2-mCherry (right) expressed at their endogenous loci, respectively. (**C**) As in (**B**) for ∆*mic60* cells. (**D**--**E**) Left: individual channels and a merged image of ∆*mic60* cells expressing mito-TagBFP as well as both Qcr2-mCherry and Atp2-EGFP expressed at their endogenous loci. Right: single plane images in 0.4 µm steps of the cell shown on the left. Scale bars: (**B**, **C**) 3 μm; (**D**, **E**) 1 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.013](10.7554/eLife.07739.013)10.7554/eLife.07739.014Figure 4---figure supplement 4.Mic27 assemblies localize adjacent to the cristae marker Qcr2.(**A**--**N**) Left: examples of z-projections of confocal fluorescence microscopy images of ∆*mic60* cells expressing mito-TagBFP as well as Mic27-EGFP and Qcr2-mCherry expressed from their endogenous loci. Right: tracings of mitochondrial perimeter (blue), Qcr2-positive regions of the perimeter (red), and Mic27 foci (green) identified from image on left (as in [Figure 4E](#fig4){ref-type="fig"}). (**O**) Quantification of the mitochondrial perimeter, the Qcr2-positive perimeter, the number of Mic27 foci identified, and the number of Mic27 foci adjacent to Qcr2 signal from each example shown in (**A**--**N**) and [Figure 4E](#fig4){ref-type="fig"}. Scale bars: 1 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.014](10.7554/eLife.07739.014)10.7554/eLife.07739.015Figure 4---figure supplement 5.Mic27 assemblies localize adjacent to the cristae marker Atp2.(**A**--**B**) Left: individual channels and merged images of ∆*mic60* cells expressing mito-TagBFP as well as both Atp2-mCherry and Mic27-EGFP expressed at their endogenous loci. Right: single plane images in 0.4 µm steps of the cell shown on the left. Arrows indicate the position of Mic27 foci. Scale bars: 1 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.015](10.7554/eLife.07739.015)

To test this, we examined the requirement of individual respiratory complexes for Mic27/Mic10/Mic12 subcomplex formation/stability by generating cells deficient for respiratory complex assembly factors for Complex III, IV, or ATP synthase (∆*cbs1*, ∆*mss51*, or ∆*atp10*, respectively) in ∆*mic60* cells expressing Mic27-EGFP ([@bib15]). Deletion of each respiratory complex assembly factor caused a significant decrease in the percentage of cells containing Mic27 foci (from 86% to 44--63%; [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). This observation indicates that individual respiratory complexes contribute to Mic27/Mic10/Mic12 subcomplex formation/stability, but are not essential. Together, our data indicate that respiratory complexes function in a somewhat redundant manner in the assembly/stability of Mic27/Mic10/Mic12.

The complete absence of respiratory complexes in rho^0^ cells corresponds to a loss of detectable characteristic cristae as assessed by EM analysis ([@bib20]). Thus, we considered the possibility that the Mic27/Mic10/Mic12 subcomplex marks cristae junctions. Previously, we observed that cells harboring individual MICOS deletions have a 3--10-fold reduction in the frequency of cristae junctions, but that junction architecture is not altered ([@bib20]). Thus, the relatively discrete nature and low copy number of Mic27 assemblies in ∆*mic60* cells relative to the abundant assemblies in wild type cells is also consistent with its localization at cristae junctions. A direct assessment of whether Mic27-EGFP localizes to cristae junctions in ∆*mic60* cells by thin section immuno-EM was not successful due to technical challenges posed by the low copy number of cristae junctions. As an alternative, we utilized fluorescent protein fusions of respiratory complex constituents that selectively localize to cristae ([@bib57]). In wild type cells, functional markers for Complex III (Qcr2-mCherry) and ATP synthase (Atp2-mCherry) were relatively uniformly distributed as compared to the matrix marker, consistent with previous observations ([@bib57]) ([Figure 4---figure supplement 3A--3B](#fig4s3){ref-type="fig"}). In contrast, in ∆*mic60* cells, both Qcr2-mCherry and Atp2-mCherry possessed a non-uniform distribution and concentrated in discrete subregions of mitochondria as compared to the matrix marker ([Figure 4---figure supplement 3C](#fig4s3){ref-type="fig"}). In addition, Atp2-EGFP fluorescence signal marked edges of Qcr2-mCherry-labeled subregions of ∆*mic60* cells ([Figure 4---figure supplement 3D--3E](#fig4s3){ref-type="fig"}). EM analysis of ATP synthase localization in different cell types indicates that it selectively localizes in multimeric ribbons to the curved edges of cristae ([@bib49]; [@bib2]). Thus, the localization patterns of Atp2 in subregions marked by Qcr2 strongly suggests that these are lamellar, stacked cristae as visualized by EM in ∆*mic60* cells.

We tested whether Mic27 structures were localized adjacent to cristae by examining whether Mic27 foci were spatially linked to Qcr2-labeled subregions in ∆*mic60* cells. Significantly, we observed that a majority of Mic27 foci were adjacent to regions labeled by Qcr2 in ∆*mic60* cells (96% of Mic27 foci were localized close to Qcr2, which marked less than 40% of the mitochondrial perimeter, n = 15 cells; [Figure 4D--F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}). Mic27 foci also were spatially linked to Atp2 labeled subregions in ∆*mic60* cells ([Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}). Taken together our data strongly suggest that independently of Mic60, at the boundary membrane, the Mic27/Mic10/Mic12 subcomplex is positioned at cristae junctions.

Cardiolipin is required for Mic27 assemblies {#s2-5}
--------------------------------------------

We examined the role of the mitochondrial lipid environment on MICOS. In this context, the paralogous Mic27 and Mic26 contain an Apolipoprotein O-like lipid-binding domain, and the mammalian homolog, MIC27/APOOL, has been shown to specifically bind to cardiolipin in vitro ([@bib53]). In addition, members of the MICOS complex have a strong negative genetic interaction with members of the cardiolipin synthesis pathway, further suggesting that MICOS and cardiolipin act together to maintain mitochondrial function ([@bib20]). We therefore asked whether cardiolipin affected the assembly/stability of the Mic27 subcomplex in mitochondria. We examined both the localization of Mic27 and mitochondrial morphology in wild type cells and cells lacking the mitochondrial cardiolipin synthesis enzyme, Crd1. Deletion of *CRD1* led to minor mitochondrial morphology and respiratory growth defects in cells, consistent with published observations ([@bib23]; [@bib7]) ([Figure 5A,D,E](#fig5){ref-type="fig"}). In ∆*crd1* cells, the non-uniform localization pattern of Mic27 was similar to wild type cells and consistently, mass spectrometry analysis of purifications of Mic27 from ∆*crd1* cell extracts indicated that the MICOS complex was intact ([Figure 5A,C](#fig5){ref-type="fig"}, and [Figure 5---source data 1](#SD3-data){ref-type="supplementary-material"}). In contrast, we found that in ∆*mic60* ∆*crd1* cells, Mic27-EGFP foci were largely absent and Mic27 stability was reduced as compared to levels in wild type, ∆*mic60*, or ∆*crd1* cells (foci in 87% of ∆*mic60* cells vs 2% of ∆*mic60* ∆*crd1* cells; [Figure 5A--B](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). The requirement of cardiolipin for Mic27 stability and Mic27 assemblies was specific, as Mic60 foci formation was not significantly affected in ∆MICOS ∆*crd1* cells as compared to ∆MICOS cells ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). Consistent with loss of Mic27 assemblies, purification and mass spectrometry analysis of Mic27 from cross-linked ∆*mic60* ∆*crd1* cell extracts indicates a loss of interaction of Mic27 with the MICOS complex ([Figure 5C](#fig5){ref-type="fig"} and [Figure 5---source data 1](#SD3-data){ref-type="supplementary-material"}). Together, these data indicate that the association of Mic27 to the Mic27/Mic10/Mic12 subcomplex is dependent on cardiolipin and suggest that cardiolipin is required for its localization at cristae junctions.10.7554/eLife.07739.016Figure 5.Cardiolipin is required for stability of the Mic10/Mic12/Mic27 subcomplex.(**A**) Images are shown of confocal fluorescence microscopy z-projections of the indicated cells expressing Mic27-EGFP from its endogenous locus and mito-DsRed. (**B**) Quantification of the percent of cells with detectable Mic27 foci in the indicated cells. Data shown are represented as the mean ± SEM from three independent experiments with approximately 75 cells counted per experiment. (**C**) A graph depicting the number of total spectral counts identified by mass spectrometry of the indicated MICOS proteins from lysates of ∆*crd1* and ∆*mic60* ∆*crd1* cells relative to wild type cells from purifications of Mic27-EGFP with GFP antibody. (**D**) Serial dilutions of the indicated yeast cells plated on media containing glucose (left) and the non-fermentable carbon source, glyercol (right). (**E**) Quantification of mitochondrial morphologies from the indicated cells expressing mito-DsRed were categorized. Approximately 75--100 cells from three independent experiments were quantified and data are represented as mean ± SEM. Data for wild type and ∆MICOS cells are redisplayed from [Figure 1C](#fig1){ref-type="fig"}. Scale bars: 3 μm. See also [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} and [Figure 5---source data 1](#SD3-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.016](10.7554/eLife.07739.016)10.7554/eLife.07739.017Figure 5---source data 1.Table listing spectral count and percent coverage data from mass spectrometry analysis of indicated MICOS protein purifications from the indicated strains.Data from table are presented graphically in [Figure 5C](#fig5){ref-type="fig"}. In some cases, multiple experiments were performed simultaneously with a single control experiment.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.017](10.7554/eLife.07739.017)10.7554/eLife.07739.018Figure 5---figure supplement 1.Interactions between cardiolipin synthesis and MICOS.(**A**) Western blot analysis of whole cell lysates prepared from the indicated strains expressing Mic27-EGFP from its endogenous locus and detected with antibody against GFP. G6PDH was used as a loading control. (**B**) Z-projections of confocal fluorescence microscopy images of yeast cells expressing mito-DsRed and Mic60-EGFP expressed from its endogenous locus in the indicated yeast cells. Arrows mark sites of Mic60 foci formation. (**C**) Serial dilutions of the indicated yeast cells plated on media containing glucose (left) and the non-fermentable carbon source, glyercol (right). Scale bars: 2 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.018](10.7554/eLife.07739.018)

Because ∆*mic60* ∆*crd1* cells are deficient for both Mic60 and Mic27 assemblies, we asked whether their growth and mitochondrial morphological characteristics are similar to ∆MICOS cells. We observed that ∆*mic60* ∆*crd1* and ∆MICOS have comparable growth defects when utilizing glycerol as a non-fermentable carbon source ([Figure 5D](#fig5){ref-type="fig"}). In contrast, ∆*mic27 ∆crd1* cells did not have a synthetic growth defect on glycerol media ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). Additionally, deletion of *CRD1* in ∆MICOS cells did not further compromise growth on non-fermentable carbon sources ([Figure 5D](#fig5){ref-type="fig"}, compare growth of ∆MICOS ∆*crd1* vs ∆MICOS strains). Consistently, mitochondrial morphology of ∆*mic60 ∆crd1* cells was more severely affected than that observed in ∆*mic60* cells and had similar characteristics to those observed in ∆MICOS cells, with a substantial increase in the percent of cells with bulbous morphology (9% of ∆*mic60* cells compared to 36% ∆*mic60* ∆*crd1* cells) and a corresponding decrease in the percent of cells with tubular and lamellar morphology ([Figure 5A,E](#fig5){ref-type="fig"}). Together, these data indicate that in cells the absence of both Mic60 and cardiolipin partially phenocopies deletion of the entire MICOS complex and suggest that cardiolipin, in addition to its role in the assembly of respiratory chain supercomplexes, acts to promote the assembly of Mic27 into the Mic27/Mic10/Mic12 subcomplex and its localization to cristae junctions. Importantly, the genetic interaction between *CRD1* and *MIC10* differs from that of *CRD1* and *MIC27*, suggesting that there are complex interactions both within and between each MICOS subcomplex and their mitochondrial environment ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}).

Respiratory complex III and IV contribute to ∆MICOS phenotypes {#s2-6}
--------------------------------------------------------------

To understand the role of MICOS in mitochondrial respiratory function, we explored the basis of the ∆MICOS respiratory growth defect. We isolated purified mitochondria from wild type, ∆*mic60*, and ∆MICOS strains, and assessed mitochondrial respiratory complex function in vitro. Mitochondrial respiratory complexes and supercomplexes remained largely intact in both ∆*mic60* and ∆MICOS mitochondria as assessed by Blue Native PAGE (BN-PAGE) analysis relative to mitochondria isolated from wild type cells ([Figure 6A](#fig6){ref-type="fig"}). Likewise, both ATP synthase dimerization and activity were unaffected in either single MICOS deletions or ∆MICOS as assessed by an in gel activity assay ([Figure 6C](#fig6){ref-type="fig"}). However, despite the presence of mitochondrial respiratory complexes, we detected deficiencies in cytochrome-*c* oxidase (Complex IV) activity specifically in ∆MICOS and not in ∆*mic60* ([Figure 6B](#fig6){ref-type="fig"}). Using two-dimensional gel analysis, we determined that the composition of respiratory complexes in ∆*mic60* and ∆MICOS cells was indistinguishable from wild type cells ([Figure 6D](#fig6){ref-type="fig"}). These data indicate that in the absence of the MICOS complex, respiratory complexes can assemble, but do not function optimally. It is possible that in the absence of the MICOS complex, the respiratory defect results from a severe decrease in cristae junctions and consequent disorganization of the inner membrane structure. Alternatively, but not exclusively, MICOS could play a more direct role in the organization of respiratory complexes in the inner membrane.10.7554/eLife.07739.019Figure 6.Complex III and IV selectively contribute to the ∆MICOS phenotypes.(**A**) A Coomassie-stained Blue Native-PAGE gel of digitonin-solubilized mitochondria isolated from the indicated strains. Labels indicate approximate sizes of the indicated respiratory complexes and supercomplexes. (**B**--**C**) In-gel activity assays for samples run as in (**A**) for Complex IV activity (**B**) and ATP synthase activity (**C**). Molecular weight markers are shown on the left. (**D**) Top: Coomassie-stained Blue Native PAGE (BN-PAGE) gels of DDM-solubilized mitochondria isolated from the indicated strains. Labels indicate approximate sizes of the indicated respiratory complexes. Bottom: BN-PAGE analysis was followed by SDS-PAGE in a second dimension and silver staining analysis. Molecular weights markers are shown on the left. (**E**) Z-projections of confocal fluorescence microscopy images of the indicated yeast cells expressing mito-DsRed are shown. (**F**) Representative electron microscopy images are shown of chemically fixed ∆MICOS rho^0^ cells. (**G**) A graph displaying categorization of mitochondrial morphologies from the indicated cells imaged as in (**E**). Approximately 75--100 cells from three independent experiments were quantified and data are represented as mean ± SEM. Data for ∆MICOS cells are redisplayed from [Figure 1C](#fig1){ref-type="fig"}. Scale bars: (**E**) 3 μm; (**F**) 200 nm.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.019](10.7554/eLife.07739.019)

To further test this idea, we examined the relationship between respiratory complexes and the mitochondrial morphology defect in ∆MICOS cells. Specifically, we asked whether mitochondrial morphology was altered in ∆MICOS rho^0^ cells, which lack mitochondrial respiratory complexes. Strikingly, ∆MICOS rho^0^ cells exhibited relatively normal, tubular mitochondrial morphology as assessed by fluorescence microscopy of matrix-targeted dsRed as compared to ∆MICOS rho^+^ cells (10% rho^+^ cells vs 95% rho^0^ cells exhibited tubular mitochondrial morphology; [Figure 6E,G](#fig6){ref-type="fig"}). As expected, by electron microscopy, the inner membrane of ∆MICOS rho^0^ cells lacked detectable cristae and were frequently septated, suggesting that mitochondrial inner membrane fusion is compromised likely as a secondary consequence of reduced respiration ([Figure 6F](#fig6){ref-type="fig"}) ([@bib43]). Thus, in the absence of the MICOS complex, expression of respiratory complexes causes inner membrane disorganization, and consequently, severe and diverse abnormal mitochondrial morphologies. Consistently, loss of ATP synthase was previously shown to suppress the predominant lamellar mitochondrial morphology defect of ∆*mic60* cells ([@bib20]). Therefore, we asked whether deletion of individual respiratory complexes alleviated the ∆MICOS mitochondria morphological defect by deleting genes for essential assembly factors of Complex III (∆*cbs1*), Complex IV (∆*mss51*), and ATP synthase (∆*atp10*) from ∆MICOS. As in ∆*mic60* cells, deletion of ATP synthase assembly selectively suppressed the abnormal mitochondrial lamellar phenotype of ∆MICOS, but the bulbous or spherical morphologies were still present in the cell population. Only 25% of ∆MICOS ∆*atp10* cells had normal tubular morphology, compared to 10% in ∆MICOS alone, suggesting distinct morphological phenotypes present in ∆MICOS are caused by separate factors ([Figure 6E,G](#fig6){ref-type="fig"}). Consistent with this, deletion of either Complex III or IV assembly factors more significantly alleviated all types of ∆MICOS morphological defects, as ∼75% of ∆MICOS ∆*cbs1* or ∆MICOS ∆*mss51* cells had normal tubular mitochondrial morphology ([Figure 6E,G](#fig6){ref-type="fig"}). These observations, together with the reduced Complex IV activity in ∆MICOS cells, suggest that assembled respiratory Complex III and IV are not properly organized and/or positioned in ∆MICOS, leading to morphological and respiratory growth defects.

Mic19 mediates the interaction between the Mic60 and Mic27 assemblies at cristae junctions {#s2-7}
------------------------------------------------------------------------------------------

Our data indicate that, although there is functional redundancy within the MICOS complex, there are functional interrelationships between the Mic60 and Mic27/Mic10/Mic12 MICOS subcomplexes, respiratory complexes, and cardiolipin that are required for proper inner membrane organization, mitochondrial morphology, and respiratory function. To address these interrelationships, we examined how the two MICOS subcomplexes connect and the role of this connection in the proper maintenance of cristae junction number and organization in wild type cells.

We considered Mic19 as it has a functional relationship to each MICOS subcomplex; Mic19 disperses Mic60 foci in ∆MICOS and the absence of Mic19 specifically results in the formation of Mic27 focal assemblies in cells ([Figures 2, 3](#fig2 fig3){ref-type="fig"}). These data are consistent with a possible role of Mic19 as an assembly regulator of both MICOS subcomplexes. To test whether Mic19 functions as a connector, we purified tagged Mic60 and Mic27 from cross-linked ∆*mic19* extracts and identified interacting partners using mass spectrometry analysis, normalizing the total number of Mic60 or Mic27 peptide spectral counts purified from ∆*mic19* extracts relative to wild type extracts. Mass spectrometry analysis of Mic60 purifications indicated that relative to wild type extracts, the absence of Mic19 results in a significant loss of Mic60 interactions with other MICOS components ([Figure 7A](#fig7){ref-type="fig"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}). By comparison, mass spectrometry analysis of Mic27 purifications from ∆*mic19* extracts indicated that Mic27 maintains its interaction with Mic10 relative to wild type extracts ([Figure 7A](#fig7){ref-type="fig"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}). Together, our data support a model in which the soluble intermembrane space protein Mic19 functions as a primary connector between the two distinct MICOS organizing centers: Mic60 and Mic27/Mic10/Mic12.10.7554/eLife.07739.020Figure 7.Mic19 mediates an interaction between the Mic60 and Mic10/Mic12/ Mic27 subcomplexes.(**A**) A graph depicting the number of total spectral counts identified by mass spectrometry of the indicated MICOS proteins from lysates of ∆*mic19* cells relative to wild type cells from purifications of Mic60- or Mic27-EGFP with GFP antibody. Data shown are the mean and range of two independent experiments. (**B**) Images are shown of confocal fluorescence microscopy z-projections of ∆*mic19* rho^+^ (left) and rho^0^ (right) cells expressing Mic60-EGFP from the *MIC60* locus and mito-DsRed. Arrows mark focal localization of Mic60. (**C**) Z-projections are shown of confocal fluorescence microscopy images of ∆*mic19* cells expressing mito-TagBFP as well as Mic60-EGFP and Mic27-mCherry expressed from their endogenous loci. Arrows indicate sites of Mic60 and Mic27 colocalization. (**D**) Single plane confocal fluorescence microscopy images in 0.4 µm steps through a ∆*mic19* cell expressing Mic60-EGFP and the Complex III marker Qcr2-mCherry at their endogenous loci and the mitochondrial matrix marker mito-TagBFP. Arrows indicate the position of Mic60 foci. (**E**) As in (**D**) for cells expressing Atp2-mCherry. (**F**) A schematic model of the organization and roles of MICOS and its constituent subcomplexes. The model also depicts the interrelationship between MICOS, cardiolipin, and respiratory complexes, and the coordination of these factors in generating mitochondrial inner membrane organization and cristae architecture. Scale bars: (**B**) 3 μm; (**C**) 2 μm; (**D**, **E**) 1 μm. See also [Figure 7---figure supplements 1--2](#fig7s1 fig7s2){ref-type="fig"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.020](10.7554/eLife.07739.020)10.7554/eLife.07739.021Figure 7---source data 1.Table listing spectral count and percent coverage data from mass spectrometry analysis of indicated MICOS proteins.Data are presented graphically in [Figure 7A](#fig7){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.021](10.7554/eLife.07739.021)10.7554/eLife.07739.022Figure 7---figure supplement 1.Cardiolipin synthesis is not required for Mic60 foci formation in ∆*mic19* cells.Z-projections of confocal fluorescence microscopy images of yeast cells expressing mito-DsRed and Mic60-EGFP expressed from its endogenous locus in the indicated yeast cells. Arrows mark sites of Mic60 foci formation. Scale bars: 2 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.022](10.7554/eLife.07739.022)10.7554/eLife.07739.023Figure 7---figure supplement 2.Mic60 assemblies localize adjacent to the cristae markers Qcr2 and Atp2.(**A**--**B**) Left: individual channels and merged images of ∆*mic19* cells expressing mito-TagBFP as well as both Qcr2-mCherry and Mic60-EGFP expressed at their endogenous loci. Right: single plane images in 0.4 µm steps of the cell shown on the left. Arrows indicate the position of Mic60 foci. (**C**--**D**) As in (**A**--**B**) for cells expressing Atp2-mCherry. Right panel of (**A**) and (**C**) redisplayed from [Figure 7D--E](#fig7){ref-type="fig"}. Scale bars: 1 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07739.023](10.7554/eLife.07739.023)

We next addressed the hierarchical relationship between the Mic60 and Mic27/Mic10/Mic12 MICOS subcomplexes. Mic60 assembles independently of the MICOS complex and its interactions with other MICOS members are significantly reduced in ∆*mic19* cells ([Figures 2B, 7A](#fig2 fig7){ref-type="fig"}). Consistent with these data, we observed that Mic60 localizes to focal assemblies in ∆*mic19* cells ([Figure 7B](#fig7){ref-type="fig"}). We tested the relationship between Mic60 and Mic27/Mic12/Mic10 assemblies in ∆*mic19* cells expressing Mic60-EGFP and Mic27-mCherry. We found that the focal localization of Mic60 and Mic27 overlapped, suggesting Mic60 assemblies also mark cristae junctions ([Figure 7C](#fig7){ref-type="fig"}, see arrows). Consistently, Mic60 assemblies in ∆*mic19* cells localized adjacent to discrete mitochondrial subregions labeled by the cristae markers Qcr2 and Atp2, further supporting their localization to cristae junctions ([Figure 7D--E](#fig7){ref-type="fig"} and [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). Mic60 assemblies in ∆*mic19* cells persist in the absence of mtDNA and cardiolipin synthesis ([Figure 7B](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Thus, while it is possible that the co-localization of Mic60 with Mic27 in ∆*mic19* cells is due to direct interactions between the Mic60 and Mic27/Mic10/Mic12 subcomplexes, the behavior of Mic60 assemblies in ∆*mic19* cells is consistent with that of Mic60 assemblies in ∆MICOS cells. These observations suggest that Mic60 structures may independently mark cristae junctions in cells. Their persistence in ∆MICOS rho^0^ cells, which lack detectable cristae further suggests that Mic60 functions upstream of the Mic27/Mic10/Mic12 subcomplex to position nascent sites of cristae junction formation within mitochondria ([Figures 4A, 6F](#fig4 fig6){ref-type="fig"}). In the context of our data supporting a role of Mic19 as a MICOS subcomplex regulator and connector, we propose that Mic19 coordinately regulates the assembly of MICOS to dictate the copy number and distribution of cristae in the inner membrane.

Discussion {#s3}
==========

Our analysis indicates that MICOS consists of two subcomplexes, which localize to cristae junctions ([Figure 7F](#fig7){ref-type="fig"}). Examination of the assembly pathways for each subcomplex has illuminated their relative roles in cristae biogenesis. The Mic27/Mic12/Mic10 subcomplex is dependent on the inner membrane phospholipid cardiolipin and on the expression of respiratory complexes. The second MICOS subcomplex consists of a Mic60 multimer, which assembles in a manner independent of cardiolipin, respiratory complexes, and other MICOS proteins. Although each subcomplex assembles independently, the cardiolipin- and respiratory complex-independent nature of Mic60 assemblies suggest that there is a hierarchical nature to MICOS assembly, where Mic60 functions upstream of the Mic27/Mic10/Mic12 subcomplex in MICOS assembly. In this context, we observed Mic60 assemblies in cells without mtDNA, which lack detectable cristae by electron microscopic analysis. These observations suggest that Mic60 assemblies direct the position of nascent cristae junction sites.

The underlying molecular basis for how Mic60 assemblies are positioned within mitochondria is not currently understood, but is likely critical for inner membrane organization. One possibility is that outer membrane-associated determinants direct the biogenesis and/or placement of Mic60 assemblies. Consistent with this, Mic60 independently interacts with components of the mitochondrial import and sorting machinery complex (SAM/TOB) through its conserved 'mitofilin' domain ([@bib25]; [@bib59]). These interactions may allow Mic60 to facilitate proper spacing between the inner boundary and outer membranes and/or to organize these specific outer membrane components relative to inner membrane cristae. Mitochondrial internal determinants may also contribute to the assembly and position of Mic60, such as the mtDNA-independent replisome, which could function to coordinate cristae biogenesis with nucleoid placement ([@bib32]). Alternatively, but not exclusively, it is possible that Mic60 assembles at mitochondrial lipid sub-domains positioned, for example, by contacts between mitochondria and the ER ([@bib26]).

The role of the Mic27/Mic12/Mic10 subcomplex is suggested by its dependence on cardiolipin and respiratory complexes. Cardiolipin is also required for the assembly and activity of respiratory complexes and for the formation of respiratory supercomplexes, which are processes that do not depend on MICOS. Thus, our observations suggest that Mic27/Mic12/Mic10 may instead directly sense cardiolipin-rich subdomains of mitochondria to coordinate the non-redundant actions of MICOS and cardiolipin in the respiratory complex-dependent formation of cristae junctions. Consistent with this, Mic26 and Mic27 both share a conserved Apolipoprotein O-like domain, which in other contexts bind to lipids. We could not detect a role for Mic26 in MICOS subcomplex assembly, although its domain architecture suggests it may also function to coordinate MICOS with the mitochondrial lipid environment. In addition, although we failed to generate a functional Mic10 fluorescent protein to directly examine its localization and behavior, the observation that Mic10 is required for Mic27 stability suggests that it plays a central role in directing the formation and function of the Mic27/Mic12/Mic10 subcomplex.

The dependence of the Mic27/Mic12/Mic10 subcomplex on respiratory complexes indicates that in addition to direct roles in cristae biogenesis, they also intrinsically contribute to this biogenesis pathway via MICOS assembly. The reciprocal is not true as we find that MICOS is not required for respiratory supercomplex assembly. However, in the absence of MICOS, the activity of cytochrome-*c* oxidase Complex IV is somewhat reduced and, more importantly, cells lacking MICOS exhibit a severe respiratory defect. One explanation for this severe defect is that MICOS\'s role in the regulation of cristae copy number is important for producing an optimal distance within cristae between the electron transporting Complex III/IV supercomplexes, localized at lamellar regions, and ATP synthase oligomers localized to the curved edges for efficient oxidative phosphorylation ([@bib42]). Our data also implicate Complex III and IV directly in the nucleation of cristae and in the process of cristae biogenesis. This is supported by the requirement of Complex III and IV for the generation of aberrant mitochondrial morphology in the absence of MICOS ([Figure 6](#fig6){ref-type="fig"}). The basis for this observation may lie in the ability of Complex III and IV to form large cardiolipin-dependent supercomplexes, which could act as diffusion traps for the cristae proteome and lipidome ([@bib55]). Recent work also implicates a role for the inner membrane fusion dynamin, OPA1, in the regulation of mitochondrial inner membrane shape and respiratory supercomplex assembly ([@bib8]). Thus, future work will be required to understand the mechanistic relationships between MICOS and respiratory complexes and OPA1 in the process of inner membrane organization.

Our analysis provides insight into the underlying mechanism of cristae copy number and distribution control. A typical wild type mitochondrion possesses many cristae positioned and distributed along the mitochondrial boundary inner membrane. We find that the only soluble MICOS protein, Mic19 functions as the key component directing the inner membrane distribution of each MICOS subcomplex. We propose that through this distributive action and its role as a connector/adaptor, Mic19 regulates the copy number of the MICOS complex and, consequently, the copy number and position of cristae junctions. In this context, it is interesting to note that Mic19 has two mammalian homologs (MIC19 and MIC25), with conserved coiled-coil-helix motifs, consistent with a role as a key regulatory component of MICOS and suggesting a structural basis for its role as a connector.

Our data indicate that the primary function of MICOS is to stabilize, position and control the copy number of cristae junctions to organize the inner membrane into an efficient respiratory machine. Aberrant cristae morphology, very similar to what we observe in cells devoid of MICOS, is a defining feature of a diverse array of human diseases and of aging, and cristae reorganization is a central facet of cytochrome *c* release in the mediation of apoptotic cell death. Thus, our observations suggest that MICOS will play a significant role in human pathogenesis.

Materials and methods {#s4}
=====================

Strains and plasmids {#s4-1}
--------------------

All yeast strains described were constructed in the W303 genetic background (*ade2--1*; *leu2--3*; *his3--11, 15*; *trp1--1*; *ura3--1*; *can1--100*). All deletions (except those used to generate the ∆MICOS strain, see below) were generated using PCR-based homologous recombination replacing the entire ORF of targeted genes with the kanMX6, HIS3MX6, or NatMX6 cassettes ([@bib29]; [@bib45]). All C-terminal tags were generated using PCR-based targeted homologous recombination using the following cassettes, and are referred to throughout the text using the description in parentheses: GFP(S65T)::HIS3MX6 (GFP), yEGFP::Kan (EGFP), yEGFP::SpHIS5 (EGFP), yEGFP::CaURA3 (EGFP), 3x-yEGFP::CaURA3 (3x-EGFP), ymCherry::HIS3MX6 (mCherry), ymCherry::Kan (mCherry), and 3xFLAG::HIS3MX6 (FLAG) ([@bib29]; [@bib47]; [@bib20]; [@bib14]). All yeast transformations were performed by the lithium acetate method and transformants were selected on the appropriate media and verified by PCR, and where appropriate, gene expression. Haploid strains containing multiple tags, deletions, or combinations thereof were generated either by mating and sporulation, or by sequential PCR-based homologous recombination. Rho^0^ versions of strains were generated by growth in YPD containing 25 μg/ml ethidium bromide for ∼48 hr.

The ∆MICOS strain was generated using the Cre-*lox P* system described previously ([@bib16]). Briefly, the *loxP*-*kanMX-loxP* cassette was PCR amplified from pUG6, integrated into the desired locus by homologous recombination replacing the ORF of the desired MICOS gene, and verified by PCR. The resulting strain was transformed with pSH47, which expresses the Cre recombinase under the control of a *GAL1* promoter. Cre was expressed by growth in YPGal for ∼16 hr. Isolated colonies were tested for loss of G418 resistance and further verified by PCR. Finally, loss of the pSH47 plasmid was selected for by growth on 5-fluoroorotic acid. This process was performed sequentially for each MICOS ORF in the following order: *MIC10, MIC60, MIC19, MIC27, MIC26,* and *MIC12*.

Untagged MICOS proteins were reintroduced into ∆MICOS in two steps. First, the kanMX6, TRP1, or HIS3MX6 selection cassettes were introduced after the stop codon of a MICOS ORF in a wild type strain using PCR-based targeted homologous recombination. Then, genomic DNA was prepared from these strains, and the entire cassette containing the MICOS ORF, selection cassette, and regions upstream and downstream of the ORF was PCR-amplified and reintroduced into the ∆MICOS strain. In the case of reintroduction of tagged MICOS proteins, the same procedure was performed using genomic DNA isolated from the tagged strains described above.

pYX142-DsRed (referred to as 'mito-DsRed') and pYX142-mtGFP (referred to as 'mito-GFP') were previously described ([@bib54]; [@bib13]). To construct pVT100u-mito-TagBFP (referred to as 'mito-TagBFP'), yeast codon optimized TagBFP was synthesized de novo as a gBlock (IDT), digested and inserted into the KpnI/XhoI sites of pVT100u-mtGFP ([@bib54]), replacing GFP. All mitochondria plasmid-containing yeast strains were generated by lithium acetate transformation and selection on synthetic dextrose (SD) media.

To construct pRS306-Mic60-EGFP (referred to as 'pMic60-EGFP'), a DNA fragment containing the *MIC60* promoter, the Mic60 ORF fused to EGFP, and the *ADH* terminator was PCR amplified from genomic DNA isolated from a yeast strain expressing Mic60-EGFP at the *MIC60* locus. This fragment was digested and cloned into the BamHI/NotI sites of pRS306 ([@bib48]). To construct pRS305-Rim1-GFP (referred to as 'Rim1-GFP'), a GFP tag was first integrated at the C-terminus of the Rim1 ORF using pFA6a-GFP(S65T)-kanMX6. A cassette containing the *RIM1* promoter, the Rim1 ORF (including its intron), GFP(S65T), and the *ADH* terminator was PCR amplified from genomic DNA from this strain and cloned into the XhoI/NotI sites of pRS304. pMic60-EGFP and Rim1-GFP integrate at the *ura3-1* and *leu2-3* loci, respectively, and were introduced by linearization (using ApaI for pMic60-EGFP and EcoRV for Rim1-GFP) and lithium acetate transformation, followed by selection on SD media. Expression was verified by fluorescence microscopy.

Yeast growth assays {#s4-2}
-------------------

Cells were grown to exponential phase in YPD, pelleted, and resuspended in water at a concentration of 0.5 OD~600~/ml. 5 μl of 10-fold serial dilutions were plated on YPD and YPEG plates and cells were grown for ∼36 hr (YPD) and ∼48 hr (YPEG) at 30°C.

Fluorescence microscopy {#s4-3}
-----------------------

For all fluorescence microscopy experiments, cells were grown to exponential phase in SD with appropriate plasmid selection, concentrated, and spread on a 3% low-melt agarose pad set on concave microscope slides.

Images in [Figure 2](#fig2){ref-type="fig"} were captured with a DeltaVision Real Time (GE Healthcare Life Sciences; Picastaway, NJ) microscope using a 60×, 1.4 NA objective and a CoolSnap HQ camera (Photometrics; Tuscon, AZ). Z-series were taken with a 0.2 μm step size. Images were deconvolved using SoftWoRx software (GE Healthcare Life Sciences), and ImageJ (NIH; Bethesda, MD) was used to make linear adjustments to images.

For all other fluorescence images, including quantification of morphology and foci, Z-series of cells using a 0.2 μm step size were collected using the spinning-disk module of a Marianas SDC Real Time 3D Confocoal-TIRF microscope (Intelligent Imaging Innovations; Denver, CO) fitted with a 100×, 1.46 NA objective and either a Photometrics QuantEM EMCCD camera or a Hamamatsu (Japan) Orca Flash 4.0 sCMOS camera. Images were captured with SlideBook (Intelligent Imaging Innovations) and linear adjustments were made using ImageJ. Morphological and foci counting analysis was performed manually using ImageJ and for each experiment, at least 75 cells from at least three fields of view were quantified.

To quantify the localization of Mic27 foci relative to Qcr2 in cells ([Figure 4D--F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}), cells where Qcr2-mCherry was localized to mitochondrial subregions when compared to mito-TagBFP were chosen blind to Mic27 signal. Single plane images were compared to maximum z-projections to confirm the z-projection was representative of cell appearance. Qcr2 signal was considered positive when it was above an arbitrary threshold using the 'Moments' algorithm of ImageJ. Tracings of the mitochondrial perimeter and subregions of the perimeter adjacent to Qcr2 were manually performed. After identifying Qcr2-positive mitochondrial subregions, Mic27 foci were identified blind to Qcr2 signal and then compared to the Qcr2-positive regions of the tracings. Finally, Mic27 foci were scored as adjacent or not to Qcr2 signal in the z-projection and verified in the single plane images.

Electron microscopy {#s4-4}
-------------------

Preparation of cells for morphology was performed as described previously described ([@bib41]). Briefly, cells were pelleted and fixed in 3% glutaraldehyde contained in 0.1 M sodium cacodylate, pH 7.4, 5 mM CaCl~2~, 5 mM MgCl~2~, and 2.5% sucrose for 1 hr at 22°C with gentle agitation, spheroplasted, embedded in 2% ultra low temperature agarose (prepared in water), cooled, and subsequently cut into small pieces (1 mm^3^). The cells were then postfixed in 1% OsO~4~/1% potassium ferrocyanide contained in 0.1 M cacodylate/5 mM CaCl~2~, pH 7.4, for 30 min at 22°C. The blocks were washed thoroughly 4 times with double-distilled H~2~O (ddH~2~O; 10 min in total), transferred to 1% thiocarbohydrazide at 22°C for 3 min, washed in ddH~2~O (4 times for 1 min each), and transferred to 1% OsO~4~/1% potassium ferrocyanide in cacodylate buffer, pH 7.4, for an additional 3 min at 25°C. The cells were washed 4 times with ddH~2~O (15 min in total), en bloc stained in Kellenberger\'s uranyl acetate for 2 hr to overnight, dehydrated through a graded series of ethanol, and subsequently embedded in Spurr resin. Sections were cut on an ultramicrotome (Ultracut T; Reichert), poststained with uranyl acetate and lead citrate, and observed on a transmission electron microscope (Tecnai 12;FEI; Hillsboro, OR) at 100 kV. Images were recorded with a digital camera (Soft Imaging System MegaView III; Olympus; Japan), and figures were assembled in Photoshop (Adobe; San Jose, CA) with only linear adjustments in contrast and brightness.

Whole cell extracts {#s4-5}
-------------------

Cells were grown to exponential phase in YPD, and whole cell lysates of 0.25 OD~600~ cells were obtained by alkaline extraction (0.255 M NaOH, 1% beta-mercaptoethanol) followed by precipitation in 9% trichloroacetic acid. Precipitates were washed in acetone, dried, and resuspended in MURB protein sample buffer (100 mM MES, pH 7.0, 1% SDS, 3 M urea, 10% β-mercaptoethanol).

Immunopurification and proteomic analysis {#s4-6}
-----------------------------------------

Immunopurifications were performed as previously described ([@bib20]), except 1000 OD~600~ cells were used. Briefly, cells were grown to exponential phase in YPD, resuspended in lysis buffer (20 mM HEPES pH7.4, 150 mM KOAc, 2 mM Mg(Ac)~2~, 1 mM EGTA, 0.6 M sorbitol, and 1× Protease Inhibitor Mixture I \[EMD Millipore; Billerica, MA\]), flash-frozen dropwise in liquid N~2~, and lysed using a Freezer/Mill (SPEX; Metuchen, MJ). As described, the cell lysate was cleared, cross-linked for 30 min with 1 mM DSP (Thermo Fisher Scientific; Waltham, MA), solubilized with 1% digitonin for 30 min, and pelleted again. The resulting supernatant was used for purifications with either 3 μg α-FLAG antibody (1:1000, Sigma--Aldrich; St. Louis, MO) and 50 μl μMACS protein G beads (Miltenyi Biotec; San Diego, CA), or with 50 μl μMACS α-GFP MicroBeads (Miltenyi Biotec), and beads were isolated with μ columns and a μMACS separator (Miltenyi Biotec). For Western blot analysis, samples were eluted from beads with MURB sample buffer. For mass spectrometry proteomic analysis, samples were eluted using on-bead trypsin digestion as described previously and submitted to the University of California, Davis, Genome Center Proteomics Core. Sample processing and LC-MS/MS analysis were performed as previously described ([@bib20]). Raw data from each mass spectrometry run are shown in source data files. For comparative analysis of MICOS interactions in different strain backgrounds, we normalized using the relative number of total immunopurified spectral counts in the mutant extracts to wild type extracts. All graphs of proteomic analyses display the range of values from duplicate experiments.

Mic60 solubility analysis {#s4-7}
-------------------------

Mitochondria from wild type or ∆MICOS cells expressing Mic60-EGFP tagged at its endogenous locus were isolated by differential centrifugation as described previously ([@bib20]). Mitochondria were resuspended in lysis buffer (20 mM HEPES pH7.4, 0.6 M sorbitol, 1 mM DTT, 0.1 M NaCl, 1× Protease Inhibitor Mixture I, and 1% Triton X-100) and incubated on ice for 30 min, followed by centrifugation at 50,000×*g* for 60 min (TLA-100, Beckman Coulter; Brea, CA). Total, supernatant, and pellet fractions were resuspended in equivalent volumes of MURB sample buffer, and analyzed by Western blotting.

Western blot analysis {#s4-8}
---------------------

Samples were boiled for 5 min and analyzed by SDS-PAGE, transferred to PVDF or nitrocellulose, and immunoblotted with the following primary antibodies at the indicated concentrations: mouse α-FLAG (1:1000, Sigma--Aldrich); mouse α-GFP (1:2000, UC Davis NeuroMab clone N86/8) or (1:2000, Thermo Fisher Scientific clone GF28R); rabbit α-mCherry (1:2000, Thermo Fisher Scientific); rabbit α-G6PDH (1:2000, Sigma--Aldrich); mouse α-Porin (1:1000, Thermo Fisher Scientific). The appropriate secondary antibodies conjugated to DyLight 680 and DyLight 800 (1:10000, Thermo Fisher Scientific) were used and visualized with the Odyssey Infrared Imaging System (LI-COR; Lincoln, NE). Linear adjustments to images were made using Adobe Photoshop.

BN-PAGE analysis, in gel activity assays, and two-dimensional gel anaylsis {#s4-9}
--------------------------------------------------------------------------

Crude mitochondrial extracts were isolated by differential centrifugations as described previously ([@bib20]). Blue native electrophoresis (BN-PAGE) was performed in 4--16% gradient gels according to the recommendation of the Novex NativePAGE Bis-Tris gel System (Thermo Fisher Scientific). Briefly, 100 µg of isolated mitochondria was solubilized with 6 g digitonin per g mitochondrial protein. The extracts were centrifuged at 4°C for 15 min at 20,000×*g*, and aliquots of the supernatant (20 µl) were immediately loaded on the top of a 4--16% polyacrylamide gel. After electrophoresis, the gel was divided into strips, which were incubated in different solutions at room temperature for 20 min to 1 hr to reveal in gel activity. In order to reveal in gel ATPase activity, gel strips were incubated in a solution of 5 mM ATP, 5 mM MgCl~2~, 0.05% lead acetate, 50 mM glycine--NaOH pH 8.4. For the cytochrome-*c* oxidase activity, strips were incubated in the following solution (diaminobenzidine 0.6% \[wt/vol\], bovine heart cytochrome *c* 1.2% \[wt/vol\], 1 nM catalase, 50 mM H~2~PO~4~, pH:7).

The Blue Native/SDS-PAGE two-dimensional analysis was performed as previously described ([@bib56]). Briefly, BN-PAGE was first performed as above except mitochondria were solubilized with 1 g n-Dodecyl β-D-maltoside (DDM) per g mitochondrial protein. After BN-PAGE, the gel was divided into strips which were incubated in 1% SDS buffer for 2 hr. The strips were then placed on top of a 16% Tricine-SDS polyacrylamide gel ([@bib44]). After electrophoresis in the second dimension, the gel was stained by classical silver staining.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for choosing to send your work entitled "MICOS, respiratory complexes and mitochondrial lipids coordinately build a functional mitochondrial inner membrane" for consideration at *eLife*. Your full submission has been evaluated by Vivek Malhotra (Senior editor) and two peer reviewers, one of whom, Richard Youle, is a member of our Board of Reviewing Editors, and the decision was reached after discussions between the reviewers and editors. Based on our discussions, we find that your manuscript, albeit of considerable interest, cannot be accepted for publication in its current form. You will need to provide new data to support your proposal, but if you are able to address the concerns in a timely manner we would request the same reviewers for their recommendation.

Four major issues were raised by the reviewers that would need to be resolved experimentally:

1\) The work would benefit from more EM or super resolution analyses of MICOS protein localizations relative to predicted cristae junctions. Currently, protein localization assessments are indirect (near Ox Phos complex proteins in [Figure 7D](#fig7){ref-type="fig"}) and of low resolution. An important conclusion is that the Mic27/Mic10/Mic12 complex localizes to cristae junctions independent of Mic60. This is based on the correlated locations of Mic27 and respiratory complexes presented in [Figures 4D and E](#fig4){ref-type="fig"}. At least a quantification (which is admittedly a challenge on its own) of the proximity of Mic27 to Qcr2 and Atp2 and addressing whether they are more adjacent to each other than to some other mitochondrial substructure (nucleoids?) is needed to support this conclusion. This would assure that not everything is close together within mitochondria visualized at this low resolution. However, immune-Ems would be the best solution.

2\) One related issue is the identification of MICOS "subcomplexes" found when subsets or individual components of MICOS are expressed in delta MICOS cells. Could the Mic60 foci in [Figure 2](#fig2){ref-type="fig"} be misfolded aggregates? Perhaps expression of Mic19 stabilizes Mic60 allowing it to fold more normally. Immuno-EM may allow the authors to support the claim that Mic60 labels discrete structures (cristae junctions?) rather than forming nonspecific aggregates. Or perhaps blue native gels would support the contention that Mic60 forms discrete substructures. It would be important to back up or substantiate the authors' conclusion at the end of the subsection headed "Mic10, Mic12, and Mic27 form a second independent MICOS organizing center" that Mic60 "has an intrinsic self-organizational capacity" above and beyond self-aggregation. Self-aggregation may also explain why Mic60 foci form in Rho0 cells. On the other hand, [Figure 7C](#fig7){ref-type="fig"} shows that Mic60 forms focal assemblies in Mic19 null cells that overlap with Mic27. This supports the authors' idea that Mic60 is localized to actual substructures but in [Figure 7](#fig7){ref-type="fig"} (relative to [Figure 2](#fig2){ref-type="fig"}) location of Mic60 may be influenced by other MICOS proteins and prevent aggregation.

3\) The authors describe that alterations in cardiolipin affect Mic27/10/12 assembly, but not the Mic60/19 sub complex, which is consistent with the previous notion that mammalian Mic27 binds cardiolipin. However, loss of cardiolipin leads to disassembly of respiratory chain super complexes, which have been linked to cristae morphogenesis. It remains unclear how the authors distinguish between a direct effect of cardiolipin on Mic27 from that caused by an assembly defect of respiratory chain super complexes (even more as they observe that impaired assembly of respiratory complexes affects MICOS sub complexes).

4\) Based on in-gel assays of respiratory chain complexes the authors propose that the loss of MICOS complexes does not affect assembly, but localization/positioning of respiratory complexes and thus impair their activity. This is highly speculative. Is it possible that complex IV lacks accessory factor(s) in MICOS-deficient cells? The authors should at least perform EM analysis to examine whether deletions of CBS1 or MSS51 restore cristae in the absence of Mic60 or MICOS.

Two more minor issues were also raised that would be valuable to address:

A\) The point made in the Abstract that MICOS subunits have non-redundant functions has already been reported by the authors and others (Dev. Cell 21:694, 2011; FEBS J. 280:4943, 2013). For thoroughness, these prior papers describing non-redundant import related functions of Mic60 should be cited to high light the non-redundant genetic interactions (Hoppins 2011).

B\) The dependence of Mic27/10/12 assemblies on mitochondrial DNA and their functional link to respiratory complexes is very intriguing. However, it is unclear how MICOS complexes affect mtDNA and vice versa. Restoration of cristae structures upon loss of the ATP synthase ([@bib20]) or upon the loss of mtDNA ([@bib21]) has been described and the reported findings do not provide significant new insight into the molecular basis of these observations.
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Author response

*1) The work would benefit from more EM or super resolution analyses of MICOS protein localizations relative to predicted cristae junctions. Currently, protein localization assessments are indirect (near Ox Phos complex proteins in* [*Figure 7D*](#fig7){ref-type="fig"}*) and of low resolution. An important conclusion is that the Mic27/Mic10/Mic12 complex localizes to cristae junctions independent of Mic60. This is based on the correlated locations of Mic27 and respiratory complexes presented in* [*Figures 4D and E*](#fig4){ref-type="fig"}*. At least a quantification (which is admittedly a challenge on its own) of the proximity of Mic27 to Qcr2 and Atp2 and addressing whether they are more adjacent to each other than to some other mitochondrial substructure (nucleoids?) is needed to support this conclusion. This would assure that not everything is close together within mitochondria visualized at this low resolution. However, immune-Ems would be the best solution*.

We agree that one important point suggested by our data is that both Mic60 and Mic27/10/12 subcomplexes independently localize to cristae junctions. Data supporting this conclusion include the dependence of Mic27 foci formation on the presence of cristae as well as the adjacent localization of Mic27 foci to cristae-localized respiratory complex proteins *∆mic60* cells. We agree that more equivocal support would include immuno-EM data demonstrating more directly the localization of Mic27 to cristae junctions. However, immuno-EM analysis of Mic27 in *∆mic60* cells, as mentioned in the manuscript, proved too technically challenging because of the low abundance of both cristae junctions and Mic27 foci in *∆mic60* cells and the difficulty associated with visualizing cristae junctions in thin section. However, in order to determine if this problem was specific to *∆mic60* cells, we performed immuno-labeling of Mic60 in both *∆mic19* cells and ∆MICOS cells. We obtained images of gold particle clusters specific for Mic60 at the edges of mitochondria (as observed for Mic27 immuno-gold labeling), which likely correspond to the focal appearance we observe by fluorescence. However as seen previously for Mic27, we could not determine whether these were spatially linked to cristae junctions because of the morphology of the mitochondrial membranes in these thin sections.

Given the importance of this conclusion, however, we further analyzed our light imaging data by quantitatively assessing the proximity of Mic27 and Mic60 foci to substructures labeled by Qcr2 and Atp2, proteins previously demonstrated to be enriched in cristae. Per the reviewers' request, we acquired higher resolution images using a CMOS camera with ∼2x greater pixel density (see new [Figure 4D-4E](#fig4){ref-type="fig"}, Figure 4--figure supplement 5-6, [Figure 7D-7E](#fig7){ref-type="fig"}, and Figure 7--figure supplement 3). We think these images convincingly demonstrate the localization of both Mic27 and Mic60 foci immediately adjacent to submitochondrial-concentrated regions of Qcr2 and Atp2. Thus, to further test this, we developed an unbiased quantitative analysis method of these higher resolution images, which indicates that the localization pattern of Mic27 foci adjacent to Qcr2-labled cristae is non-random (see new [Figure 4D-4F](#fig4){ref-type="fig"} and [Figure 4--supplement 5](#fig4s5){ref-type="fig"}).

*2) One related issue is the identification of MICOS* "*subcomplexes*" *found when subsets or individual components of MICOS are expressed in delta MICOS cells. Could the Mic60 foci in* [*Figure 2*](#fig2){ref-type="fig"} *be misfolded aggregates? Perhaps expression of Mic19 stabilizes Mic60 allowing it to fold more normally. Immuno-EM may allow the authors to support the claim that Mic60 labels discrete structures (cristae junctions?) rather than forming nonspecific aggregates. Or perhaps blue native gels would support the contention that Mic60 forms discrete substructures. It would be important to back up or substantiate the authors' conclusion at the end of the subsection headed "Mic10, Mic12, and Mic27 form a second independent MICOS organizing center" that Mic60* "*has an intrinsic self-organizational capacity*" *above and beyond self-aggregation. Self-aggregation may also explain why Mic60 foci form in Rho0 cells. On the other hand,* [*Figure 7C*](#fig7){ref-type="fig"} *shows that Mic60 forms focal assemblies in Mic19 null cells that overlap with Mic27. This supports the authors' idea that Mic60 is localized to actual substructures but in* [*Figure 7*](#fig7){ref-type="fig"} *(relative to* [*Figure 2*](#fig2){ref-type="fig"}*) location of Mic60 may be influenced by other MICOS proteins and prevent aggregation*.

To address the concern that Mic60 foci represent misfolded aggregateswe simply tested whether Mic60 behaves as a soluble protein upon detergent solubilization of isolated mitochondria extracts under low salt conditions (see new [Figure 2E](#fig2){ref-type="fig"}), To address the concern that Mic60 foci represent misfolded aggregates, we simply tested whether Mic60 behaves as a soluble protein upon detergent solubilization of isolated mitochondria extracts under low salt conditions (see new [Figure 2E](#fig2){ref-type="fig"}). Specifically, we solubilized mitochondria from wild type and ∆MICOS cells expressing Mic60-EGFP using 100mM NaCl and 1% TX-100 and performed a 50,000g spin for 1h, which is sufficient to pellet protein aggregates 60S or greater (equivalent to ∼2 MDa 60S ribosome). Under these conditions, Fcj1-GFP in both the wild type (sized at 0.6 to 1.5 MDa in published work) and in ∆MICOS mitochondrial extracts was quantitatively recovered in the supernatant fraction. These data indicate that Mic60-EGFP foci in ∆MICOS cells do not represent non-specific aggregates, and are likely self-assemblies or form as a consequence of another determinant.

*3) The authors describe that alterations in cardiolipin affect Mic27/10/12 assembly, but not the Mic60/19 sub complex, which is consistent with the previous notion that mammalian Mic27 binds cardiolipin. However, loss of cardiolipin leads to disassembly of respiratory chain super complexes, which have been linked to cristae morphogenesis. It remains unclear how the authors distinguish between a direct effect of cardiolipin on Mic27 from that caused by an assembly defect of respiratory chain super complexes (even more as they observe that impaired assembly of respiratory complexes affects MICOS sub complexes)*.

In our model ([Figure 7F](#fig7){ref-type="fig"})we include the possibility that the effect of cardiolipin on respiratory supercomplex assembly may indirectly influence Mic27 subcomplex assembly, In our model ([Figure 7F](#fig7){ref-type="fig"}), we include the possibility that the effect of cardiolipin on respiratory supercomplex assembly may indirectly influence Mic27 subcomplex assembly. However, while decreases in cardiolipin are linked to disassembly of respiratory chain super complexes, to date there is no link between cristae morphogenesis and supercomplex formation in yeast cells, with the exception of ATP synthase dimerization, which is not altered by loss of cardiolipin in cells. However, it is possible that cardiolipin synthesis may indirectly regulate Mic27 subcomplex assembly through an effect on respiratory complex assembly, but not through defects in cristae morphogenesis. An equally probable possibility suggested by our data is that Mic27 subcomplexes may directly sense cardiolipin through its apolipoprotein-like domain. We have made sure not to overstate this conclusion.

*4) Based on in-gel assays of respiratory chain complexes the authors propose that the loss of MICOS complexes does not affect assembly, but localization/positioning of respiratory complexes and thus impair their activity. This is highly speculative. Is it possible that complex IV lacks accessory factor(s) in MICOS-deficient cells? The authors should at least perform EM analysis to examine whether deletions of CBS1 or MSS51 restore cristae in the absence of Mic60 or MICOS*.

Our data do not definitively determine the cause of the respiratory defect in the absence of MICOS, Our data do not definitively determine the cause of the respiratory defect in the absence of MICOS, beyond noting that there is a subtle defect in complex IV activity. However, our analysis also indicates that respiratory complexes and supercomplexes are intact in ∆MICOS cells. In order to test the status of respiratory complex composition more thoroughly, we performed 2D native SDS-PAGE gel analysis of detergent-solubilized purified mitochondria (see new [Figure 6D](#fig6){ref-type="fig"}). These data show no apparent defects in the composition of assembled respiratory complexes in either ∆mic60 or ∆MICOS cells, indicating that ∆MICOS cells do not lack complex IV accessory factor(s). We are currently delving into the cause of the respiratory deficiency in ∆MICOS cells by examining suppressors, but we think that this is beyond the scope of the current study.

The reviewers also suggest that we perform EM analysis on cells deficient for Complex III or IV assembly factors to test if cristae are restored in ∆MICOS cells in their absence. Based on this suggestion, the reviewers likely misunderstood our data from ∆MICOS rho0 cells. Specifically, in ∆MICOS cells only aberrant mitochondrial morphology is restored upon loss of respiratory complexes (rho0), not cristae structure ([Figure 6F](#fig6){ref-type="fig"}). Indeed, restoration of morphology correlates with loss of cristae in rho0 cells, which indicates that the aberrant cristae, observed by light imaging of Qcr2, causes mitochondrial morphological defects in ∆MICOS, a finding we previously published for single MICOS subunit deletion cells (Hoppins et al. JCB 2011). Thus, while deletion of CBS1 and MSS51 partially restore tubular morphology in ∆MICOS cells ([Figure 6E and 6G](#fig6){ref-type="fig"}), this is not mediated through restoration of cristae morphology.

*Two more minor issues were also raised that would be valuable to address*:

*A) The point made in the Abstract that MICOS subunits have non-redundant functions has already been reported by the authors and others (Dev. Cell 21:694, 2011; FEBS J. 280:4943, 2013). For thoroughness, these prior papers describing non-redundant import related functions of Mic60 should be cited to high light the non-redundant genetic interactions (Hoppins 2011)*.

We thank the reviewer for this suggestion and have now specifically highlighted the MICOS-independent import-related function of Mic60 in the Introduction. While the FEBS J reference the reviewer suggested shows a Mic60-specific role in accumulation of mutant Sod1, this is not necessarily an import-related function of Mic60, and thus we do not cite it here.

*B) The dependence of Mic27/10/12 assemblies on mitochondrial DNA and their functional link to respiratory complexes is very intriguing. However, it is unclear how MICOS complexes affect mtDNA and vice versa. Restoration of cristae structures upon loss of the ATP synthase (*[@bib20]*) or upon the loss of mtDNA (*[@bib21]*) has been described and the reported findings do not provide significant new insight into the molecular basis of these observations*.

As stated above for point 4, loss of ATP synthase ([@bib20]) or loss of mtDNA ([@bib20] and [@bib21]) have been shown to alleviate mitochondrial morphology defects in the absence of MICOS components, however, neither work shows a restoration of normal cristae morphology. Our data indicate that mitochondrial DNA is maintained in ∆MICOS cells (though nucleoids often appear mis-distributed) ([Figure 1E](#fig1){ref-type="fig"}) and correspondingly, respiratory complexes are still expressed and assembled in ∆MICOS cells ([Figure 6A](#fig6){ref-type="fig"}). However, as stated for in our response to point 4 above, in ∆MICOS cells, deletion of respiratory complex assembly factors or loss of mtDNA causes loss of cristae, which is what is correlated with the suppression of mitochondrial morphological defects, not the restoration of cristae structure. The link between the presence of respiratory complexes and Mic27/10/12 assemblies but not Mic60 assemblies is a conceptual advance because it suggests that Mic60 marks nascent cristae sites and that Mic27/10/12 assemblies are recruited/assembled following cristae biogenesis driven by ATP synthase and respiratory complexes.
